Physician

Gaurav Gupta, M.D.

According to 2025 Medicare claims, Gaurav Gupta, M.D. (NPI: 1366559114) practices ophthalmology in the Providence-Warwick, RI-MA market, with the plurality of this provider's patient population coming from Providence, RI. This provider's primary affiliated billing organization is REFOCUS EYE HEALTH OF RI, LLC (NPI: 1043938772; TIN: 874175575) and primary practice location at 02906-5131. Gupta is affiliated with the Lifespan Health Alliance, LLC (ACO ID: A3336), participating under the MSSP model.

Gupta's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 833 traditional Medicare patients, billed 10,330 HCPCS/CPT codes, and received $1,776,492 in Medicare payments. The top billing code was J0178 (Injection, aflibercept, 1 mg). Part D data shows 445 prescription claims across 154 beneficiaries totaling $43,469 in drug costs, led by Bromfenac Sodium (Bromfenac Sodium). Open Payments data shows 16 records totaling $375. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing did not follow a clear longitudinal pattern. Concurrently, Part D prescription costs have moved from a lower plateau to a higher plateau, from $11,424 to $43,469. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Part B Carrier Billing Trend. X-axis: year 2015-2024. Y-axis: Medicare payment, unit: USD. Field: Tot_Mdcr_Pymt_Amt. Source: Medicare Physician & Other Practitioners by Provider.0$1.2M$2.4M2015 Medicare payment: $1,506,327 (USD; Tot_Mdcr_Pymt_Amt)2016 Medicare payment: $1,522,449 (USD; Tot_Mdcr_Pymt_Amt)2017 Medicare payment: $1,781,357 (USD; Tot_Mdcr_Pymt_Amt)2018 Medicare payment: $2,375,248 (USD; Tot_Mdcr_Pymt_Amt)2019 Medicare payment: $2,354,486 (USD; Tot_Mdcr_Pymt_Amt)2020 Medicare payment: $2,341,573 (USD; Tot_Mdcr_Pymt_Amt)2021 Medicare payment: $2,284,357 (USD; Tot_Mdcr_Pymt_Amt)2022 Medicare payment: $1,969,570 (USD; Tot_Mdcr_Pymt_Amt)2023 Medicare payment: $1,981,417 (USD; Tot_Mdcr_Pymt_Amt)2024 Medicare payment: $1,776,492 (USD; Tot_Mdcr_Pymt_Amt)2015201620172018201920202021202220232024
YearPatientsClm LinesPayment
20158677,610$1,506,327
20169087,560$1,522,449
20178447,982$1,781,357
20188448,913$2,375,248
20198899,068$2,354,486
20207638,524$2,341,573
20218137,987$2,284,357
20228467,272$1,969,570
202382610,024$1,981,417
202483310,330$1,776,492

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Part D Events Trend. X-axis: year 2015-2024. Y-axis: Drug cost, unit: USD. Field: Tot_Drug_Cst. Source: Medicare Part D Prescribers by Provider.0$24K$47K2015 Drug cost: $11,424 (USD; Tot_Drug_Cst)2016 Drug cost: $9,961 (USD; Tot_Drug_Cst)2017 Drug cost: $20,202 (USD; Tot_Drug_Cst)2018 Drug cost: $28,640 (USD; Tot_Drug_Cst)2019 Drug cost: $40,105 (USD; Tot_Drug_Cst)2020 Drug cost: $30,456 (USD; Tot_Drug_Cst)2021 Drug cost: $24,325 (USD; Tot_Drug_Cst)2022 Drug cost: $37,823 (USD; Tot_Drug_Cst)2023 Drug cost: $47,174 (USD; Tot_Drug_Cst)2024 Drug cost: $43,469 (USD; Tot_Drug_Cst)2015201620172018201920202021202220232024
YearPatientsClaimsDrug Cost
201580211$11,424
201667177$9,961
201788223$20,202
2018137386$28,640
2019161452$40,105
2020121386$30,456
2021117338$24,325
2022138400$37,823
2023132347$47,174
2024154445$43,469

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

No connected DME records

No connected DME records

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

CodeDescriptionPatientsClm LinesTotal Payment
J0178Injection, aflibercept, 1 mg1861,892$648
92004New patient complete exam of visual system7070$101
92014Established patient complete exam of visual system625939$91
67028Injection of drug into eye2271,169$84
92134Imaging of retina7932,011$30

Top 5 Part D drugs in 2024

By total drug costs.

DrugGenericClaimsTotal Day SupplyTotal Drug Cost
Bromfenac SodiumBromfenac Sodium742,464$17,444
RestasisCyclosporine15450$9,348
ProlensaBromfenac Sodium26808$9,042
Prednisolone AcetatePrednisolone Acetate963,142$4,075
Ketorolac TromethamineKetorolac Tromethamine29847$844

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

CategoryDefinitionRecordsTotal Reported AmountTop Related Entity
General PaymentsReported payment or transfer-of-value amount.16$375Regeneron Healthcare Solutions, Inc.
Research PaymentsReported research-related payment or transfer-of-value amount.0$0N/R
Ownership / Investment InterestsReported value of ownership or investment interests.0$0N/R

FAQ

What Medicare data is available for Gaurav Gupta, M.D.?

Tedicare shows public-source Medicare data for Gaurav Gupta, M.D. (NPI 1366559114), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Gaurav Gupta, M.D. have ACO affiliation data?

Gaurav Gupta, M.D. is shown with ACO affiliation data for Lifespan Health Alliance, LLC (MSSP, ACO ID A3336).

What billing organization is linked to Gaurav Gupta, M.D.?

Gaurav Gupta, M.D. is linked to REFOCUS EYE HEALTH OF RI, LLC (billing NPI 1043938772) in the available physician profile data.

Does Gaurav Gupta, M.D. have Open Payments data?

Gaurav Gupta, M.D. has 16 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.